Rights and permissions
About this article
Cite this article
COX-2 inhibitor use increased after formulary listing in Canada. Pharmacoecon. Outcomes News 392, 5 (2002). https://doi.org/10.1007/BF03279961
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279961